The Turkish Version of the Medial Tibial Stress Syndrome Score

November 19, 2022 updated by: Merve Demir Benli, Bozyaka Training and Research Hospital

The Reliability and Validity of the Turkish Version of the Medial Tibial Stress Syndrome (MTSS-Tr) Score

The medial tibial stress syndrome (MTSS) score was originally developed in Dutch to assess severity of disease relative to patient-reported outcome, particularly patients with MTSS. The purpose of this study was to translate and cross-culturally adapt the MTSS score into Turkish and investigate its psychometric properties.

Study Overview

Status

Completed

Detailed Description

The medial tibial stress syndrome (MTSS) score was originally developed in Dutch to assess severity of disease relative to patient-reported outcome, particularly people with MTSS. The purpose of this study was to translate and cross-culturally adapt the MTSS score into Turkish and investigate its psychometric properties. Fourty-eight individuals with MTSS will include. Within a 7-day period after the first assessment, the participants completed the Turkish version of the MTSS score to evaluate test-retest reliability.

Cronbach's alpha (α) was used to assess internal consistency. Construct validity was examined total score of PCS domain of SF-36-Tr with MTSS-Tr total score in the first visit. Concurrent validity was examined by evaluating the relationship between pain level and Detmer's classification with MTSS score in the first visit. The pain level of the patient assessed with visual analog scale (VAS) score.

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey
        • Tepecik Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This study will include 48 patients diagnosed with medial tibial stress syndrome (MTSS) by the sports medicine physicians in İzmir Bozyaka Training and Research Hospital, Tepecik Training and Research Hospital and Ege University. The individuals who volunteers and meets the inclusion criteria will be included in the study.

Description

Inclusion Criteria:

  • Patients diagnosed with MTSS by a sports medicine physician
  • Patients aged between 18 and 75 years
  • Patients whose native language is Turkish
  • Patients who volunteered to participate in the study

Exclusion Criteria:

  • Having tibia fracture history,
  • Patients with suspected stress fracture or chronic compartment syndrome,
  • Pregnant and breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medial Tibial Stress Syndrome Score
Time Frame: Baseline (First assessment)
The MTSS total score is a reliable and valid tool to assess severity in patient with MTSS. The 14-item MTSS score was designed to assessing limitations in sporting activities, pain while performing sporting activities, pain while performing activities of daily living and pain at rest. Items have four response options with descriptors for each response category. Higher item scores indicate a more severe pain or limitation and hence more severe MTSS symptoms. Participants were asked to fill out the MTSS score with their most painful shin in mind, in case of bilateral symptoms.
Baseline (First assessment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medial Tibial Stress Syndrome Score
Time Frame: Within a 7-day period after the first assessment (Second assessment)
The MTSS total score is a reliable and valid tool to assess severity in patient with MTSS. The 14-item MTSS score was designed to assessing limitations in sporting activities, pain while performing sporting activities, pain while performing activities of daily living and pain at rest. Items have four response options with descriptors for each response category. Higher item scores indicate a more severe pain or limitation and hence more severe MTSS symptoms. Participants were asked to fill out the MTSS score with their most painful shin in mind, in case of bilateral symptoms.
Within a 7-day period after the first assessment (Second assessment)
36-Item Short Form Survey (SF-36)
Time Frame: Baseline (First assessment)
The SF-36 is widely used to measure a variety of domains, including pain and limitations while performing activities of daily living, and also in musculoskeletal and sports medicine-related research. Short Form Health Survey (SF-36), which includes two main domains, the physical component score (PCS) and the mental component score (MCS), has been widely used worldwide in studies to assess the health status burden of people and consists of 36 questions that are clustered to yield eight health status scales: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, mental health, reported health transition. The total score of PCS and MCS from 0 to 100, with higher scores indicating higher levels of function and/or better health.
Baseline (First assessment)
MTSS clinical classification (Detmer's classification)
Time Frame: Baseline (First assessment)
Physical examination evaluates the localization of pain at the posteromedial edge of tibia. According to the MTSS classification created by Detmer et al.; it is classified as Type 1 in the presence of tenderness only on the tibia, Type 2 in the posteromedial of the tibia at the junction of the periosteum and fascia, and Type 3 in the presence of tenderness in the deep compartment muscles of the posterior tibia.
Baseline (First assessment)
Evaluating the applicability of the questions
Time Frame: Within a 7-day period after the first assessment (Second assessment)
Participants evaluate the MTSS questionnaire with additional three Likert-type questions in the first assessment. In the continuation of these questions, there is also a comment section about the simplicity of filling out the survey and the convenience and usefulness of this survey.
Within a 7-day period after the first assessment (Second assessment)
Visual Analog Scala (VAS)
Time Frame: Baseline (First assessment)
Pain is graded from 0 to 10 by Visual Analog Scala (VAS). 0 indicates the least pain and 10 the most pain. The patient gives a value on this scale for the pain she/he feels.
Baseline (First assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Merve Demir Benli, MD, Bozyaka Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 20, 2022

Primary Completion (Actual)

October 6, 2022

Study Completion (Actual)

October 13, 2022

Study Registration Dates

First Submitted

May 26, 2022

First Submitted That Met QC Criteria

May 26, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

November 22, 2022

Last Update Submitted That Met QC Criteria

November 19, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Medial Tibial Stress Syndrome

Subscribe